Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer
2016 · Annals of Oncology · 59 citations
https://doi.org/10.1093/annonc/mdw132
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
266
Citations
6
h-index
5
i10-index
M Marty is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Cancer Treatment and Pharmacology & HER2/EGFR in Cancer Research & Breast Cancer Treatment Studies. The author has an h-index of 6, co-authored 16 publications.
https://doi.org/10.1093/annonc/mdw132
https://doi.org/10.1093/annonc/mdt531
Click to start Chat